Related Experiment Videos
Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathy
Sonia Carturan1, Dario Roccatello, Elisa Menegatti
1Department of Medicine and Experimental Oncology, University of Turin, Turin, Italy.
Journal of Nephrology
|December 14, 2004
Summary
Genetic variations in transforming growth factor beta1 (TGF-beta1) were studied in immunoglobulin A nephropathy (IgAN). A specific TGF-beta1 gene haplotype, TAC, was significantly associated with an increased risk of developing IgAN.
Area of Science:
- Genetics
- Nephrology
- Molecular Biology
Background:
- Transforming growth factor beta1 (TGF-beta1) regulates cellular functions and extracellular matrix remodeling.
- Immunoglobulin A nephropathy (IgAN) is a common glomerular disease with complex etiology.
- Genetic factors are implicated in the pathogenesis of IgAN.
Purpose of the Study:
- To investigate the association between specific polymorphisms (G-800A, C-509T, Leu10-->Pro) in the TGF-beta1 gene and the risk of developing IgAN.
- To determine if these TGF-beta1 gene variations contribute to the development and progression of IgAN.
Main Methods:
- Genotyping of 101 IgAN patients and 118 healthy controls using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP).
- Analysis of G-800A, C-509T, and Leu10-->Pro polymorphisms in the TGF-beta1 gene.
- Haplotype reconstruction to assess combined effects of linked polymorphisms.
Main Results:
- No significant differences in individual TGF-beta1 polymorphism genotype distributions were found between IgAN patients and controls.
- The TAC haplotype (comprising Leu10, G-800A, and C-509T alleles) showed a significant association with IgAN (p=0.043, OR=2.334).
Conclusions:
- Haplotype analysis of TGF-beta1 gene polymorphisms may be more informative than single nucleotide polymorphism analysis for identifying IgAN risk.
- Further studies with larger cohorts are required to validate the role of TGF-beta1 in IgAN and explore other variants.